Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study by Masatoshi Kudo, Kaoru Tsuchiya, Yu-Yun Shao, Richard S. Finn, Peter R. Galle, Michel Ducreux, Ann-Lii Cheng, Tatsuya Yamashita, Hironori Koga, Ryosuke Take, Kyoko Yamada, Takashi Asakawa, Yuki Nakagawa, Masafumi Ikeda

Subjects: Get full text

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab by Anna Krystyna Britton, Basil Bamford Crayford

Subjects: Get full text

Predictive Biomarkers for Bevacizumab in Anti-tumor Therapy by Qingqing PAN, Mengzhao WANG

Subjects: “…Bevacizumab…”
Get full text

Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment by Ping Liu

Subjects: Get full text

Single-shot bevacizumab for cerebral radiation injury by Martin Voss, Katharina J. Wenger, Emmanouil Fokas, Marie-Thérèse Forster, Joachim P. Steinbach, Michael W. Ronellenfitsch

Subjects: Get full text

Complications of intrastromal bevacizumab injection in lamellar keratoplasty by Mohammad Soleimani, Ahad Shahbazi, Nader Mohammadi, Seyed Ali Tabatabaei

Get full text

Cancer therapy and cardiovascular risk: focus on bevacizumab by Economopoulou P, Kotsakis A, Kapiris I, Kentepozidis N

“…Keywords: bevacizumab, cardiovascular toxicity, hypertension…”
Get full text

Using intravitreal bevacizumab (Avastin®) – Indian Scenario by Atul Kumar, Raghav Ravani

Get full text

Safety Analysis of Bevacizumab in Ovarian Cancer Patients by Yingwen Wang, Hao Lin, Yuche Ou, Hungchun Fu, Chingchou Tsai, Chanchao Chang Chien, Chenhsuan Wu

Subjects: “…bevacizumab…”
Get full text

Intravitreal bevacizumab for treatment of central serous chorioretinopathy by Cihan Ünlü, Gurkan Erdogan, Tugba Aydogan, Betul Ilkay Sezgin Akcay, Esra Kardes, Gulunay Akcali Kiray, Tahir Kansu Bozkurt

Subjects: “…Intravitreal Bevacizumab (Avastin); Central Serous Chorioretinopathy; Macular Thickness; Observation…”
Get full text

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy by Srikant Padhy, Vinod Kumar

Subjects: “…Bevacizumab…”
Get full text

Intravitreal Bevacizumab (Avastin) Injection for Neovascular Glaucoma by Shahin Yazdani, Kamran Hendi, Mohammad Pakravan

“…After obtaining informed consent, both eye received an intravitreal injection of 2.5 mg (0.1 ml) bevacizumab (Avastin). Both eyes demonstrated dramatic IOP reduction together with decreased severity and extent of NVI during 4 weeks of follow up. …”
Get full text

Therapeutical evaluation of bevacizumab application in relapsed pterygium by Mayara Martins Abrahão, Leonardo Pinheiro Teixeira, Denise Borges de Andrade Mendanha, Luana Miranda Campos, Mateus Martins Cortez Vilar, João Jorge Nassaralla Junior

Subjects: Get full text

Critical appraisal of bevacizumab in the treatment of ovarian cancer by Yoshida H, Yabuno A, Fujiwara K

“…Bevacizumab is a humanized monoclonal antibody targeting vascular endothelial growth factor. …”
Get full text

Addition of Bevacizumab to Temsirolimus in Kidney Cancer Patients by H. Boyle, S. Négrier

Subjects: Get full text

Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis by Swetha Tatineni, Zachary Warren, Mark A. Applebaum, Fuad M. Baroody

“…Recently, systemic bevacizumab has shown promise in advanced, treatment-resistant papillomatosis. …”
Get full text

Direct antitumor activity of bevacizumab: an overlooked mechanism? by Zhiyong Wang, Jiaqi Li, Jinjin Guo, Pei Wei

Subjects: Get full text

Bevacizumab combined with re-irradiation in recurrent glioblastoma by Lei She, Lei She, Lei She, Lin Su, Chao Liu

Subjects: Get full text

Bevacizumab in maintenance therapy for ovarian cancer patients by L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, E. V. Verenikina, S. N. Kabanov, Ya. V. Svetitskaya, N. Yu. Samaneva, N. M. Tikhanovskaya, K. A. Novoselova, O. G. Selezneva, A. V. Tishina

“…Bevacizumab mainterned partial response or stabilization in 76.9% of patients. …”
Get full text

The Advantage of Bevacizumab in Treating Colorectal Brain Metastasis by Hung-Ming Chen, Hao-Wei Teng

Subjects: Get full text